| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Mirabegron |
| Brand | Betmiga® |
| Indication | Symptomatic treatment of urgency, increased micturition frequency and/or urgency incontinence as may occur in adult patients with overactive bladder (OAB) syndrome. |
| Assessment Process | |
| Rapid review commissioned | 19/12/2012 |
| Rapid review completed | 12/03/2013 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation not Recommended |